Search

Your search keyword '"Kojima, Kensuke"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Kojima, Kensuke" Remove constraint Author: "Kojima, Kensuke" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
37 results on '"Kojima, Kensuke"'

Search Results

1. Supplemental File 3 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

2. Supplemental File 1 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

3. Supplemental File 2 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

4. Supplemental File 1 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

5. Supplemental File 3 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

6. Supplemental Information from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

7. Supplemental Information from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

8. Supplemental Figures 1 and 2 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

9. Data from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

10. Supplemental Methods from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

11. Supplemental File 2 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

14. Supplemental Tables 1-8 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

16. Supplemental Methods from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

20. Supplemental Tables 1-8 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

23. Data from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

25. Data from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

27. Supplemental Figures 1 and 2 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

28. Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

29. Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

32. Abstract 340: Mitochondrial priming of new targeted agents in acute myeloid leukemia

33. Abstract A38: Steatohepatitis-associated hepatocellular carcinoma: Evidence of a keratin-based disease.

Catalog

Books, media, physical & digital resources